Scrip is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Orgentec Diagnostika GmbH

www.orgentec.com

Latest From Orgentec Diagnostika GmbH

Device/Diagnostics Quarterly Deal Statistics, Q3 2014

Device financing decreased to $734 million in Q3, less than half the Q2 total, and the $4.9 billion in M&As was a sharp decline versus Q2. Diagnostics fundraising, at $399 million, showed a 31% drop from Q2, and Merck KGAA’s $16.7 billion buy of Sigma-Aldrich made up 96% of the Q3 M&A activity.

Medical Device Deals

Medical Device Deals Update, October 2014

Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Medical Device Deals Update column is a survey of recent medtech M&A, alliance, and financing activity. This month’s column covers deals announced September-October 2014.

Medical Device

Deals In Depth: August 2014

In a transaction worth $650 million in pre-commercial payments, Daiichi Sankyo got exclusive US rights to Charleston Labs’ hydrocodone combos for pain; Roche acquired two of its partners, InterMune and Santaris. Both biopharma and device financing were down in August compared with July.

BioPharmaceutical Medical Device

U.S. Government Engages Dx Firms For Rapid, Field-Based Ebola Test

Multiple companies are receiving funding or are in discussions with federal agencies about development of rapid assays for Ebola that can be used by patients and health care workers in the field, a top official at the National Institute of Allergy and Infectious Diseases told "The Gray Sheet."

Medical Device Clinical Trials
See All

Company Information

  • Industry
  • In Vitro Diagnostics
    • Chemistry, Immunoassay
  • Services
  • Therapeutic Areas
  • Blood & Coagulation Disorders & Products
  • Gastrointestinal
  • Immune Disorders
  • Infectious & Viral Diseases
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • Germany
  • Parent & Subsidiaries
  • Orgentec Diagnostika GmbH
  • Senior Management
  • Werner Hofacher, CEO
  • Contact Info
  • Orgentec Diagnostika GmbH
    Phone: (0) 6131 / 9258-
    Carl-Zeiss-Straße 49 - 51
    Mainz, 55129
    Germany
Advertisement
Advertisement
UsernamePublicRestriction

Register